Skip to main content

Table 1 Inclusion and exclusion criteria

From: The PROCEM study protocol: Added value of preoperative contrast-enhanced mammography in staging of malignant breast lesions - a prospective randomized multicenter study

Inclusion criteria Planned primary surgery for suspected or verified primary breast malignancy
Age ≥ 18 years
Signed informed consent
Exclusion criteria Planned neoadjuvant therapy
On-going pregnancy
Iodinated contrast agent allergy
Renal disease or abnormal S-creatinin (normal range 45–90 μmol/l)
Untreated thyrotoxicosis (including multinodular goitre) (upon suspicion check P-thyrotropin level, exclusion if < 0.4 mIE/l)
Severe heart failure
Myastenia gravis
Breast implant
Local recurrence as index lesion
Inability to understand oral or written information about the study